Leprosy Reactions In Childhood: A Prospective Cohort Study In The Brazilian Amazon

• Published in: Infection and drug resistance 2019-01, Vol.12, p.3249-3257
• Main Authors: Bandeira, Sabrina Sampaio, Pires, Carla Avelar, Quaresma, Juarez Antonio Simões
• Format: Article
• Language: English
• Subjects: Adrenocorticotropic hormone; Age; Amazon; Analysis; Brazil; Childhood; Children; Classification; clinical aspects; Cohort analysis; Corticosteroid drugs; Corticosteroids; Cushing syndrome; Diagnosis; Disabilities; Epidemiology; Erythema; Erythema nodosum; Glucocorticoids; Leprosy; Medical referrals; Medical research; Mycobacterium leprae; Nervous system diseases; Neuritis; Neurologic examination; Original Research; Patients; Pediatrics; Physicians; Pituitary; Quality of life; Questionnaires; Skin; Skin diseases; Skin lesions; Software; Studies; Surveys; Variables
• ISSN: 1178-6973; 1178-6973
• DOI: 10.2147/IDR.S217181

In highly endemic areas, severe multibacillary forms of leprosy and reactional episodes are not rare in children. The objective of the present study was to describe the clinical and epidemiological aspects of leprosy reactions in children from the Brazilian Amazon. This was a prospective cohort study of 34 leprosy patients aged under 15 years diagnosed at a health referral unit in northern Brazil between April 2014 and June 2015. Follow-up medical consultations were performed during multidrug therapy (MDT) and one year after the end of treatment. Participants underwent a simple neurologic examination and answered a structured questionnaire. Of the 34 recruited patients, 18 (52.9%) had leprosy reactions and/or neuritis. Among these, 10 (55.6%) had reactions at diagnosis, 13 (72.2%) had reactions after MDT, and 14 (77.8%) had two or more reactional episodes. Type I reactions occurred in 14 (77.8%) cases. Complications, such as disabilities, necrotizing erythema nodosum, or Cushing's syndrome, occurred in six (33.3%) patients. The following variables showed significant associations (p ≤ 0.05) with leprosy reactions: age 8-14 years, number of doctors seen (≥3), multibacillary classification, number of skin lesions (≥10), or borderline and lepromatous clinical forms. The high frequency of type I reactions resulted in prolonged corticosteroid therapy, which may cause deficient bone maturation in childhood. Older age in children, consulting many physicians for diagnosis, severe clinical forms, and numerous skin lesions were positively associated with reaction development. Reactions after MDT highlight the need for continuity in healthcare of children with leprosy.